-+ 0.00%
-+ 0.00%
-+ 0.00%

Biomarin Pharmaceuticals to buy Amicus Therapeutics for $4.8 billion, and the company's stock soars 30% ahead of the market

Zhitongcaijing·12/19/2025 13:17:10
Listen to the news
Biomarin Pharmaceuticals to buy Amicus Therapeutics for $4.8 billion, and the company's stock soars 30% ahead of the market